Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Mehta

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Neurology|May 20, 1999
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSFF Hulstaert, K Blennow, A Ivanoiu, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injuryM R Emmerling, M C Morganti-Kossmann, T Kossmann, et al.
Journal of Neurochemistry|December 1, 1998
Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluidC A Raby, M C Morganti-Kossmann, T Kossmann, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's diseaseM J de Leon, L Mosconi, K Blennow, et al.
Neuroscience Letters|November 14, 2002
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairmentM J de Leon, S Segal, C Y Tarshish, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Neurology|May 20, 1999
Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSFF Hulstaert, K Blennow, A Ivanoiu, et al.
Annals of the New York Academy of Sciences|May 20, 2000
Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injuryM R Emmerling, M C Morganti-Kossmann, T Kossmann, et al.
Journal of Neurochemistry|December 1, 1998
Traumatic brain injury increases beta-amyloid peptide 1-42 in cerebrospinal fluidC A Raby, M C Morganti-Kossmann, T Kossmann, et al.
Annals of the New York Academy of Sciences|April 7, 2007
Imaging and CSF studies in the preclinical diagnosis of Alzheimer's diseaseM J de Leon, L Mosconi, K Blennow, et al.
Neuroscience Letters|November 14, 2002
Longitudinal cerebrospinal fluid tau load increases in mild cognitive impairmentM J de Leon, S Segal, C Y Tarshish, et al.
Neurobiology of Aging|August 30, 2005
Longitudinal CSF and MRI biomarkers improve the diagnosis of mild cognitive impairmentM J de Leon, S DeSanti, R Zinkowski, et al.
Annals of Clinical Biochemistry|April 4, 2009
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's diseaseN A Verwey, W M van der Flier, K Blennow, et al.
Pageof 11